Scott H Kaufmann

Scott H Kaufmann

UNVERIFIED PROFILE

Are you Scott H Kaufmann?   Register this Author

Register author
Scott H Kaufmann

Scott H Kaufmann

Publications by authors named "Scott H Kaufmann"

Are you Scott H Kaufmann?   Register this Author

99Publications

1706Reads

-Profile Views

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.

Cancer Med 2019 Apr 18. Epub 2019 Apr 18.

Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.1996
Publisher Site
http://dx.doi.org/10.1002/cam4.1996DOI Listing
April 2019

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

Cell Metab 2018 Dec 30;28(6):833-847.e8. Epub 2018 Aug 30.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2018.08.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281770PMC
December 2018

Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.

J Hepatol 2018 06 9;68(6):1228-1238. Epub 2018 Mar 9.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.01.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960421PMC
June 2018

Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.

Biochem Pharmacol 2018 06 3;152:279-292. Epub 2018 Apr 3.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2018.03.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960634PMC
June 2018

Measurement of BH3-only protein tolerance.

Cell Death Differ 2018 02 20;25(2):282-293. Epub 2017 Oct 20.

Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cdd.2017.156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762843PMC
February 2018

Doubling Down on BRCA-Mutated Cancer.

Trends Cancer 2017 11 29;3(11):743-744. Epub 2017 Sep 29.

Department of Gynecology and Obstetrics, University of Washington Medical School, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2017.09.005DOI Listing
November 2017

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.

Stem Cells Transl Med 2017 03 7;6(3):840-850. Epub 2016 Nov 7.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5966/sctm.2016-0034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442784PMC
March 2017

Mitochondrial apoptosis and BH3 mimetics.

F1000Res 2016 1;5:2804. Epub 2016 Dec 1.

Division of Oncology Research , Mayo Clinic, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.9629.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133681PMC
December 2016

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma.

Clin Cancer Res 2016 Sep 25;22(18):4746-55. Epub 2016 Mar 25.

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/03/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026552PMC
September 2016

Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms.

Clin Cancer Res 2016 08 15;22(15):3894-902. Epub 2016 Mar 15.

Department of Oncology, Mayo Clinic, Rochester, Minnesota. Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041297PMC
August 2016

Immunodetection of human topoisomerase I-DNA covalent complexes.

Nucleic Acids Res 2016 Apr 24;44(6):2816-26. Epub 2016 Feb 24.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824114PMC
April 2016

Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes.

Org Biomol Chem 2016 Apr;14(17):4103-9

Department of Medicinal Chemistry, University of Minnesota, 2231 6th Street SE, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5ob02049bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922793PMC
April 2016

Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells.

Genes Dev 2015 Oct;29(20):2140-52

Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA;

View Article

Download full-text PDF

Source
http://genesdev.cshlp.org/lookup/doi/10.1101/gad.267997.115
Publisher Site
http://dx.doi.org/10.1101/gad.267997.115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617978PMC
October 2015

Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells.

Proc Natl Acad Sci U S A 2015 Aug 27;112(32):9860-5. Epub 2015 Jul 27.

Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1414754112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538638PMC
August 2015

Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.

Biochim Biophys Acta 2015 Jul 27;1853(7):1658-71. Epub 2015 Mar 27.

Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01674889150009
Publisher Site
http://dx.doi.org/10.1016/j.bbamcr.2015.03.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429517PMC
July 2015

Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.

J Clin Oncol 2015 Apr 16;33(12):1397-406. Epub 2015 Mar 16.

Clare L. Scott, Walter and Eliza Hall Institute of Medical Research and Royal Melbourne Hospital, Parkville, Victoria, Australia; Elizabeth M. Swisher, University of Washington, Seattle, WA; and Scott H. Kaufmann, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.8848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517072PMC
April 2015

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.

J Cell Biol 2014 Sep 22;206(7):867-76. Epub 2014 Sep 22.

Department of Molecular Pharmacology and Experiment Therapeutics, Division of Oncology Research, Division of Infectious Diseases, and Department of Medicine, University of Alabama, Birmingham, AL 35294 Department of Biochemistry and Molecular Biology and Department of Molecular Medicine, Mayo Clinic, Rochester MN 55905

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1083/jcb.201405051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178959PMC
September 2014

Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.

J Biol Chem 2014 Aug 27;289(33):22835-49. Epub 2014 Jun 27.

From the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.563064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132787PMC
August 2014

Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.

Mol Oncol 2014 May 24;8(3):656-68. Epub 2014 Jan 24.

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Royal Women's Hospital, Parkville, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria 3052, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.01.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400120PMC
May 2014

Context-dependent antagonism between Akt inhibitors and topoisomerase poisons.

Mol Pharmacol 2014 May 25;85(5):723-34. Epub 2014 Feb 25.

Divisions of Oncology Research (M.G.-P., K.S.F., D.A.L., K.L.P., P.A.S., S.H.K.) and Medical Oncology (C.E.), Department of Oncology and Department of Molecular Pharmacology & Experimental Therapeutics (S.H.K.), Mayo Clinic College of Medicine, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.113.088674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990016PMC
May 2014

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

Clin Cancer Res 2014 Mar 7;20(5):1288-97. Epub 2014 Jan 7.

Authors' Affiliations: Departments of Oncology, Radiation Oncology, and Molecular Pharmacology and Experimental Therapeutics; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; Division of Gynecologic Surgery; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Women's Cancer Program, Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947430PMC
March 2014

Evaluation of the BH3-only protein Puma as a direct Bak activator.

J Biol Chem 2014 Jan 21;289(1):89-99. Epub 2013 Nov 21.

From the Division of Oncology Research and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M113.505701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879582PMC
January 2014

Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Cancer Res 2013 Dec 4;73(23):6998-7008. Epub 2013 Oct 4.

Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-0940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910374PMC
December 2013

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

Cancer Res 2013 Dec 23;73(24):7222-31. Epub 2013 Oct 23.

Authors' Affiliations: Biochemistry, Molecular Biology and Biophysics Department; Masonic Cancer Center, University of Minnesota, Minneapolis; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research; Medical Genome Facility and Department of Laboratory Medicine and Pathology; Department of Laboratory Medicine and Pathology; Division of Medical Oncology, Department of Oncology; Division of Epidemiology, Department of Health Sciences Research; Division of Oncology Research, Department of Oncology; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic; Women's Cancer Program, Mayo Clinic Cancer Center, Rochester, Minnesota; Department of Cancer Biology, University of Kansas, Kansas City, Kansas; Department of Obstetrics & Gynecology, University of Washington School of Medicine, Seattle, Washington; and Illumina Cambridge Ltd, Chesterford Research Park, Little Chesterford, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867573PMC
December 2013

The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells.

Front Oncol 2013 Sep 11;3:228. Epub 2013 Sep 11.

Division of Oncology Research, Mayo Clinic , Rochester, MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769628PMC
September 2013

ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.

Cancer Res 2013 Jun 2;73(12):3683-91. Epub 2013 Apr 2.

Divisions of Oncology Research and Medical Oncology, and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687010PMC
June 2013

How does doxorubicin work?

Elife 2012 Dec 18;1:e00387. Epub 2012 Dec 18.

is in the Department of Molecular Pharmacology and Experimental Therapeutics , Mayo Clinic , Rochester , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7554/eLife.00387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524826PMC
December 2012

Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro.

Clin Cancer Res 2012 Mar 30;18(6):1655-62. Epub 2012 Jan 30.

Department of Molecular Pharmacology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-2890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306513PMC
March 2012

Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors.

Genes Dev 2012 Feb;26(4):305-11

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.186189.111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289878PMC
February 2012

Death receptor 5 signaling promotes hepatocyte lipoapoptosis.

J Biol Chem 2011 Nov 22;286(45):39336-48. Epub 2011 Sep 22.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M111.280420
Publisher Site
http://dx.doi.org/10.1074/jbc.M111.280420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234758PMC
November 2011

High cell surface death receptor expression determines type I versus type II signaling.

J Biol Chem 2011 Oct 24;286(41):35823-33. Epub 2011 Aug 24.

Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M111.240432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195573PMC
October 2011

Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.

J Cell Biol 2011 Jul 4;194(1):39-48. Epub 2011 Jul 4.

Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1083/jcb.201102027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135403PMC
July 2011

Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells.

J Biol Chem 2011 May 22;286(20):17682-92. Epub 2011 Mar 22.

Department of Molecular Pharmacology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.189092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093844PMC
May 2011

Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells.

Proc Natl Acad Sci U S A 2011 Feb 7;108(8):3406-11. Epub 2011 Feb 7.

Department of Molecular Pharmacology and Experimental Therapeutics, Radiation Oncology, and Oncology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1013715108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044391PMC
February 2011

Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.

Cancer Res 2010 Nov 14;70(21):8642-50. Epub 2010 Sep 14.

Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970685PMC
November 2010

Cancer. Targeting bacteria to improve cancer therapy.

Science 2010 Nov;330(6005):766-7

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1198310DOI Listing
November 2010

Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition.

Hepatol Res 2010 Jul 14;40(7):701-10. Epub 2010 Jun 14.

Divisions of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1872-034X.2010.00668.x
Publisher Site
http://dx.doi.org/10.1111/j.1872-034X.2010.00668.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922948PMC
July 2010

PARP inhibition: PARP1 and beyond.

Nat Rev Cancer 2010 Apr 4;10(4):293-301. Epub 2010 Mar 4.

Laval University Medical Research Center, Laval University, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910902PMC
April 2010

Prospects for the Use of ATR Inhibitors to Treat Cancer.

Pharmaceuticals (Basel) 2010 Apr 28;3(5):1311-1334. Epub 2010 Apr 28.

Division of Oncology Research, College of Medicine, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph3051311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033983PMC
April 2010

Development of PARP inhibitors: an unfinished story.

Oncology (Williston Park) 2010 Jan;24(1):66, 68

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
January 2010

Mcl-1 degradation during hepatocyte lipoapoptosis.

J Biol Chem 2009 Oct 5;284(44):30039-48. Epub 2009 Sep 5.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.039545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781558PMC
October 2009

Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.

J Clin Invest 2009 Sep 17;119(9):2714-24. Epub 2009 Aug 17.

Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI37405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735912PMC
September 2009

On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.

Bioorg Med Chem Lett 2009 Aug 18;19(15):4459-62. Epub 2009 May 18.

Division of Oncology Research, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.05.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845530PMC
August 2009

Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis.

J Biol Chem 2009 Jul 7;284(27):18311-22. Epub 2009 Apr 7.

Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.004770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709361PMC
July 2009

Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.

Gastroenterology 2009 Jun 9;136(7):2365-2376.e1-7. Epub 2009 Mar 9.

Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001650850900357
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2009.02.071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693420PMC
June 2009